Sign up
Healthed-White-on-Blue
colleen

Prof Colleen Loo

Professor of Psychiatry, UNSW & Black Dog Institute, UNSW Sydney
Colleen Loo is a psychiatrist and clinical academic researcher of the University of New South Wales, based at the Black Dog Institute. She is an active clinician and researcher, and has had a role in developing and improving treatments for severe depression : electroconvulsive therapy (ECT) and novel treatments for mood disorders, including Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS) and ketamine. She established the first randomised controlled trials of TMS, tDCS and ketamine in psychiatry in Australia. Her research program now also includes studies of psychedelic-assisted therapy. She has been active in establishing clinical practice guidelines and policy to facilitate the translation of new treatments into clinical practice. Her team of researchers also studies the use of brain stimulation to enhance cognitive functioning (in mood disorders and healthy ageing), and to treat disorders.

More from this expert

groovy2

Psychedelic medicine is on its way. Here’s what you need to know

Many people in Australia, including psychiatrists, were surprised when earlier this year the medicines regulator down-scheduled MDMA, known colloquially as ecstasy, and psilocybin, from magic mushrooms.

By Dr Nigel Strauss, Prof Colleen Loo, Prof David Jonathan Castle, Prof Steve Kisely
Clinical Articles iconClinical Articles

Discover

Healthed

CPD platform

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Register for webcast